Efficacy of a harvest graft substitute for recession coverage and soft tissue volume augmentation: A randomized controlled trial
Autor: | E. Todd Scheyer, Jim Janakievski, Rick Heard, John C. Gunsolley, Michael K. McGuire, Thiago Morelli, Diego Velasquez |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Gingiva Connective tissue Esthetics Dental law.invention Randomized controlled trial law Clinical investigation Humans Medicine Gingival Recession Tooth Root Gingival recession End point business.industry Soft tissue Gold standard (test) Root coverage Surgery Treatment Outcome medicine.anatomical_structure Connective Tissue Periodontics Collagen medicine.symptom business |
Zdroj: | Journal of Periodontology. 93:333-342 |
ISSN: | 1943-3670 0022-3492 |
Popis: | BACKGROUND The autogenous connective tissue graft (CTG) with coronally advanced flap (CTG+CAF) is the "gold standard" for recession defect coverage; however, researchers continue to pursue lower morbidity, more convenient and unlimited supply harvest graft substitutes, including those that could provide soft tissue volume augmentation. METHODS A randomized, controlled, double-masked comparison of a volume-stable collagen matrix (VCMX) versus CTG was conducted at four clinical investigation sites. Single, contralateral, within patient matched-pair, RT1 recession defects were treated with VCMX+CAF (test) and CTG+CAF (control). The primary efficacy end point was percent root coverage at 6 months. Secondary efficacy end points included clinical measures such as soft tissue volume, attachment level, and keratinized tissue width. Patient-reported outcomes included measures such as discomfort, esthetics, and overall satisfaction; 6-month end point results were followed for 1 year. RESULTS Thirty patients received control and test therapies, and all patients were available for follow-up measures. Average percent root coverage for CTG+CAF was 90.5% ± 14.87% versus 70.7% ± 28.26% for VCMX+CAF, P |
Databáze: | OpenAIRE |
Externí odkaz: |